11/07/2024
9:52 AM | BioCryst Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/07/2024
9:25 AM | BioCryst Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/05/2024
4:19 PM | BioCryst Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/04/2024
10:18 AM | BioCryst Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/04/2024
6:06 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/17/2024
10:52 AM | BioCryst Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
10/02/2024
6:06 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
09/30/2024
6:11 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/10/2024
11:09 AM | BioCryst Pharmaceuticals (Subject)
BlackRock Inc. (Filed by)
| Form SC 13G/A | |
08/05/2024
6:05 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/25/2024
3:39 PM | BioCryst Pharmaceuticals (Issuer)
McKee Amy E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
3:31 PM | BioCryst Pharmaceuticals (Issuer)
SANDERS MACHELLE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
3:27 PM | BioCryst Pharmaceuticals (Issuer)
Hutson Nancy J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
3:28 PM | BioCryst Pharmaceuticals (Issuer)
LEVIN ALAN G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
3:30 PM | BioCryst Pharmaceuticals (Issuer)
McKee Amy E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
3:31 PM | BioCryst Pharmaceuticals (Issuer)
MILANO VINCENT (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
3:33 PM | BioCryst Pharmaceuticals (Issuer)
SANDERS MACHELLE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
3:18 PM | ABERCROMBIE GEORGE B (Reporting)
BioCryst Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
3:20 PM | ASELAGE STEVE (Reporting)
BioCryst Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
3:23 PM | BioCryst Pharmaceuticals (Issuer)
Galson Steven K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
3:33 PM | BioCryst Pharmaceuticals (Issuer)
HEGGIE THERESA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2024
6:21 AM | BioCryst Pharmaceuticals (Issuer)
MILANO VINCENT (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2024
6:24 AM | BioCryst Pharmaceuticals (Issuer)
Hutson Nancy J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2024
6:08 AM | BioCryst Pharmaceuticals (Issuer)
Stonehouse Jon P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2024
6:11 AM | Barnes Alane P (Reporting)
BioCryst Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2024
6:14 AM | BioCryst Pharmaceuticals (Issuer)
Galson Steven K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2024
6:17 AM | BioCryst Pharmaceuticals (Issuer)
Thackray Helen M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2024
6:19 AM | BioCryst Pharmaceuticals (Issuer)
Doyle Anthony (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2024
6:04 AM | BioCryst Pharmaceuticals (Issuer)
Gayer Charles K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/06/2024
6:03 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/25/2024
3:26 PM | BioCryst Pharmaceuticals (Filer)
| Form ARS | |
04/02/2024
3:21 PM | BioCryst Pharmaceuticals (Issuer)
Thackray Helen M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
3:32 PM | BioCryst Pharmaceuticals (Issuer)
HEGGIE THERESA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2024
6:05 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
8:02 AM | Avoro Capital Advisors LLC (Filed by)
BioCryst Pharmaceuticals (Subject)
| Form SC 13G | |
01/24/2024
4:23 PM | BioCryst Pharmaceuticals (Subject)
BlackRock Inc. (Filed by)
| Form SC 13G/A | |
01/24/2024
12:06 PM | BioCryst Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/18/2024
4:21 PM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2024
6:02 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/20/2023
3:40 PM | BioCryst Pharmaceuticals (Issuer)
Stonehouse Jon P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2023
3:42 PM | BioCryst Pharmaceuticals (Issuer)
Thackray Helen M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Download Our Tesla Ebook For Free (Ad) Like many of you, we here at the TradingPub are bullish on Tesla long term.
We believe the company will continue to be a leader in technology, EVs and A.I.
We also believe it’s share price will be rewarded in a big way…
In fact, our #1 Tesla expert just published a brand new Ebook regarding Tesla’s future, and we’d like to send it to you at no cost. To claim your copy free of charge simply follow this link. |
12/20/2023
3:33 PM | Barnes Alane P (Reporting)
BioCryst Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2023
3:35 PM | BioCryst Pharmaceuticals (Issuer)
Doyle Anthony (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2023
3:38 PM | BioCryst Pharmaceuticals (Issuer)
Gayer Charles K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2023
3:40 PM | BioCryst Pharmaceuticals (Issuer)
Gayer Charles K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2023
3:43 PM | BioCryst Pharmaceuticals (Issuer)
Stonehouse Jon P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2023
3:47 PM | BioCryst Pharmaceuticals (Issuer)
Thackray Helen M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2023
3:34 PM | Barnes Alane P (Reporting)
BioCryst Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2023
3:37 PM | BioCryst Pharmaceuticals (Issuer)
Doyle Anthony (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/01/2023
3:42 PM | BioCryst Pharmaceuticals (Issuer)
MILANO VINCENT (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/01/2023
3:40 PM | BioCryst Pharmaceuticals (Issuer)
HEGGIE THERESA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/01/2023
6:37 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/30/2023
8:04 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Free BCRX Stock Alerts